Inventage Lab, Inc.

A389470

KR7389470006

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 24/06/2024 am IST			5-day change	1st Jan Change
10,330 ^KRW	+0.39%		+5.95%	-40.63%

2023	Inventage Lab, Inc. announced that it has received KRW 18.49998452 billion in funding from The Korea Securities Finance Corporation, Shinhan Bank	CI
2023	Inventage Lab to Raise 3 Billion Won via Stock Sale	MT

Inventage Lab, Inc. announced that it has received KRW 18.49998452 billion in funding from The Korea Securities Finance Corporation, Shinhan Bank

June 19, 2023

On June 19, 2023, Inventage Lab, Inc. closed the transaction. The comapny issued 334,074 common shares in its second and final tranche.

Latest news about Inventage Lab, Inc.

Inventage Lab, Inc. announced that it has received KRW 18.49998452 billion in funding from The Korea Securities Finance Corporation, Shinhan Bank	19/23/19	CI
Inventage Lab to Raise 3 Billion Won via Stock Sale	12/23/12	MT
Inventage Lab, Inc. announced that it expects to receive KRW 18.499980645 billion in funding from The Korea Securities Finance Corporation, Shinhan Bank	09/23/09	CI
Inventage Lab, Inc. has completed an IPO in the amount of KRW 12.48 billion.	16/22/16	CI
Inventage Lab, Inc. has filed an IPO.	10/22/10	CI

Inventage Lab Inc is a Korea-based company principally engaged in the pharmaceutical business. The Company owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The Company is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. It is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
INVENTAGE LAB, INC.	-40.63%	62.99M
ELI LILLY AND COMPANY	+52.70%	801B
NOVO NORDISK A/S	+41.58%	631B
JOHNSON & JOHNSON	-4.86%	359B
MERCK & CO., INC.	+21.96%	337B
ABBVIE INC.	+11.47%	305B
ASTRAZENECA PLC	+17.72%	245B
ROCHE HOLDING AG	+4.46%	231B
NOVARTIS AG	+13.13%	219B
AMGEN INC.	+10.46%	171B

Other Pharmaceuticals